drugset / Trial / NCT03537950
Shifting Brain Excitation-Inhibition Balance in Autism Spectrum Disorder
RandomizedCrossoverDouble-blindBasic science
Summary
This study investigates brain response to single acute dose of cannabidiol, cannabidivarin, and placebo in healthy men with and without autism spectrum disorder
Timeline
- Start
- 2016-08-22
- Primary completion
- 2017-02-16
- Completion
- 2017-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CBD | Unknown | 600 mg | Oral |
| Subject | Cannabidivarin | Small molecule | 600 mg | Oral |